Advertisement
News
Subscribe to MDT Magazine News

Select Medical 4Q profit slides 30 pct

March 4, 2011 9:45 am | by The Associated Press | Comments

Select Medical Holdings Corp. said its fourth-quarter profit dropped 30 percent due to the acquisition of Regency Hospital Co. and higher expenses.The Mechanicsburg, Pa., company said Thursday after markets closed that it earned $20.9 million, or 13 cents per share, in the three months that...

Blue Sky Biotech infused with Ampersand VC backing

March 4, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Blue Sky Biotech Inc., a Worcester-based contract research organization for the pharmaceutical industry, has taken an investment from private equity firm Ampersand Ventures of Wellesley.

TOPICS:

Medical video firm Image Stream raises $2M

March 4, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Image Stream Medical Inc., a Littleton developer of video technology for hospital operating rooms, has raised $2 million in an equity offering, according to a regulatory filing.

Advertisement

Beaumont First in State to Perform Robotic Heart Procedure for Atrial Fibrillation

March 4, 2011 8:33 am | by Bio-Medicine.Org | Comments

ROYAL OAK, Mich., March 4, 2011 /- Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery....

TOPICS:

Sigma-Aldrich to Present at Upcoming Investor Conferences

March 4, 2011 8:33 am | by Bio-Medicine.Org | Comments

ST. LOUIS, March 4, 2011 /- Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the following investor conferences in March: 31st Annual Cowen and Company Healthcare Conference on Tuesday, March 8, 2011, at the Boston Marriot Copley Place, Boston, MA, presenting at 10:15 AM...

TOPICS:

Talecris, Grifols delay closing of $3.4B deal

March 4, 2011 7:45 am | by The Associated Press | Comments

Talecris Biotherapeutics Holdings Corp. said Friday the closing of its sale to Spanish health care company Grifols SA is being delayed by almost three months.Grifols agreed to buy Talecris in June for $3.4 billion, or $26.16 per share in cash and stock. The companies had said they expected the...

Epizyme moving HQ to Vassar Street

March 4, 2011 7:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge biotech Epizyme Inc. plans to move its headquarters from Memorial Drive to 325 Vassar Street, doubling its space.

Topamax (topiramate): Label Change - Risk For Development of Cleft Lip and/or Cleft Palate in Newborns

March 4, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

Increased risk of oral clefts in infants born to women treated with Topamax (topiramate) during pregnancy.

TOPICS:
Advertisement

Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map

March 4, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., March 4, 2011 /- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs. Facing an ever-changing launch landscape,...

TOPICS:

ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology

March 4, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHICAGO, March 4, 2011 /- The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept...

TOPICS:

FDA: Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate

March 4, 2011 6:33 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 4, 2011 /PRNewswire-USNewswire/ -- New data suggest that the drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and...

TOPICS:

Surgeon General, AACR Leaders Urge Increased Investment in Research to Tackle America's Tobacco Epidemic

March 4, 2011 6:33 am | by AACR | Comments

WASHINGTON, D.C. - Stemming the tide of tobacco-related deaths and suffering and promoting public health will require renewed control efforts and further research to better understand initiation, addiction and the countless harmful effects of tobacco. These points were emphasized by U.S....

TOPICS:

Cerus 4Q loss narrows on revenue boost

March 4, 2011 5:45 am | by The Associated Press | Comments

Biotechnology company Cerus Corp. reported a smaller fourth-quarter loss on higher revenue.Cerus makes the Intercept Blood System, which inactivates blood-borne pathogens in donated blood used for transfusions.Claes Glassell, its president and CEO, said he expects slower revenue growth this...

Davol XenMatrix Surgical Graft: Class I Recall - Elevated Endotoxin Levels(2)

March 4, 2011 5:31 am | by U.S. Food & Drug Administration | Comments

Endotoxins in product can cause serious illness, at times fatal.

TOPICS:

Davol XenMatrix Surgical Graft: Class I Recall - Elevated Endotoxin Levels

March 4, 2011 5:30 am | Comments

Endotoxins in product can cause serious illness, at times fatal.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading